Europe Procedure Numbers for Orthopedic Biomaterials 2017 - MedPro
|出版商||iData Research Inc.||商品編碼||524557|
|出版日期||內容資訊||英文 460 Pages
|歐洲的整形外科用生醫材料市場上治療數量 Europe Procedure Numbers for Orthopedic Biomaterials 2017 - MedPro|
|出版日期: 2017年06月01日||內容資訊: 英文 460 Pages||
The full report suite on the U.S.European market for orthopedic biomaterials includes bone graft substitutes, which is represented by allografts, demineralized bone matrix and synthetic bone graft market. The report also includes hyaluronic acid viscosupplementation, orthopedic growth factors, orthopedic cell therapy, orthopedic cartilage repair and spinal machined bone allograft markets.
Segments Covered in this Orthopedic Biomaterials Procedure Volume Research
This market study focuses specifically on the volume of procedures in the orthopedic biomaterials market. It includes analysis of procedures in the following segments:
Bone Graft Substitute Procedures
Demineralized Bone Matrix Graft Procedures
Synthetic Graft Procedures
Cervical Spinal Procedures
Thoracolumbar Spinal Procedures
Trauma Reconstruction Procedures
Growth Factor Bone Graft Procedures
Hyaluronic Acide Treatments
Cartilage Repair Procedures
Osteochondral Allograft Procedures
Meniscal Allograft Procedures
Autologous Chondrocyte Implantation Procedures
Osteochondral Autograft Procedures
This data is then displayed over the forecast period, 2013-2023, outlining the exact growth rates for procedures in these segments. If you're interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.
About Procedure Volume Research (MedPro)
Our analysts meticulously research for 3 to 4 months to put together a suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.
This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore. For a deeper description on these product types click here or contact us to have a product consultant help you find the data you need.
Where Do We Get Orthopedic Biomaterials Procedure Data?
Our team of analysts has proprietary data that we've been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on orthopedic biomaterials procedure volumes that influence and coincide with our overall market sizing.
Trends Affecting the Orthopedic Biomaterials Market
In 2016, HA viscosupplementation represented the largest segment in the European orthopedic biomaterials market. This segment is expected to remain stable over the forecast period. The single- and three-injection cycles were the fastest growing segments in the HA market, albeit very slightly at CAGRs of 0.9% and 0.5%, respectively. However, the five-injection cycle segment was growing specifically in Germany and declining in every other market, at a CAGR of -1.5% over the forecast period. The ASP of HA products will offset any significant increase in the number of cycles sold, and thus the overall market will remain very stable over the forecast period. The BGS market was the second largest segment in the European orthopedic biomaterials market in 2016 and it is expected to grow.
Questions This Report will Help You Answer
What is affecting the volume of procedures in Europe?
How many procedures were done in 2016?
How many procedures were done historically?
How many procedures can we expect in 2023 and what is the growth trend?